Formulated for nausea and vomiting to manage symptomatic distress and support physical comfort.
Mechanism of Action
Ondansetron is a selective serotonin 5-HT3 receptor antagonist. It blocks serotonin receptors both in the peripheral vagus nerve and centrally in the chemoreceptor trigger zone, effectively preventing the nausea reflex.
Route of Administration
Oral
Onset Time
30–60 minutes
Duration
8–12 hours
Contraindications
Concurrent use of apomorphine, Hypersensitivity to ondansetron, Congenital long QT syndrome
Severe Adverse Events
Qt prolongation, Serotonin syndrome, Anaphylaxis — requires immediate medical attention
Information related to Ondansetron is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
